CMIC HOLDINGS Co., Ltd.
End-to-end pharmaceutical solutions from discovery through commercialization.
CMIC HOLDINGS is a Japanese CRO and CDMO group providing end-to-end pharmaceutical solutions from non-clinical research through manufacturing and post-market support, with recognized expertise in clinical trial management.
Phases
Services
About this organization
CMIC HOLDINGS Co., Ltd. is a comprehensive contract research and manufacturing organization serving the global pharmaceutical industry. The group offers integrated solutions spanning the entire pharmaceutical value chain:
Service Areas:
- Non-Clinical CRO services
- Clinical Research Organization (CRO) capabilities
- Contract Development and Manufacturing Organization (CDMO) services
- Sales and Marketing Organization (SMO) support
- Contract Sales Organization (CSO) services
- Consulting and regulatory affairs
Recognition: The organization was recognized as a "Winner" in the 2026 Fierce Outsourcing Awards for Clinical Trial Management, demonstrating industry-leading capabilities in clinical operations.
Scope: CMIC HOLDINGS operates as a holding company with multiple specialized subsidiaries addressing diverse pharmaceutical development and commercialization needs. The group actively participates in major industry conferences including BioJapan and DIA Japan Annual Meeting, reflecting its commitment to innovation and professional engagement in the life sciences sector.
Related companies
Similar profiles by shared services, phases, and indications.
Evanjo CRO- Phase I Clinical Trials
- Phase II Clinical Trials
SanaClis- Phase I Clinical Trials
- Phase II Clinical Trials
PCM Trials- Phase I Clinical Trials
- Phase II Clinical Trials
Krescent Medical Research- Phase I Clinical Trials
- Phase II Clinical Trials
PharPoint Research- Phase I Clinical Trials
- Phase II Clinical Trials
ProRelix Research- Phase I Clinical Trials
- Phase II Clinical Trials
ERGOMED Group- Phase I Clinical Trials
- Phase II Clinical Trials
- JSS Medical Research
- Phase I Clinical Trials
- Phase II Clinical Trials
Submit a verified review for this organization.
Markdown mirror: /companies/cmicgroup.md